198 related articles for article (PubMed ID: 1518837)
61. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
62. Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
Davies SG; Sim RB
Biosci Rep; 1981 Jun; 1(6):461-8. PubMed ID: 6170356
[TBL] [Abstract][Full Text] [Related]
63. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
64. Isolation, primary structure, and evolution of the third component of chicken complement and evidence for a new member of the alpha 2-macroglobulin family.
Mavroidis M; Sunyer JO; Lambris JD
J Immunol; 1995 Mar; 154(5):2164-74. PubMed ID: 7532662
[TBL] [Abstract][Full Text] [Related]
65. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
Emmerling MR; Spiegel K; Watson MD
Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
[TBL] [Abstract][Full Text] [Related]
66. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
67. Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.
Wang T; Secombes CJ
Immunogenetics; 2003 Dec; 55(9):615-28. PubMed ID: 14628103
[TBL] [Abstract][Full Text] [Related]
68. The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
J Mol Biol; 2007 Mar; 367(1):224-33. PubMed ID: 17234210
[TBL] [Abstract][Full Text] [Related]
69. Complement factor I and cofactors in control of complement system convertase enzymes.
Sim RB; Day AJ; Moffatt BE; Fontaine M
Methods Enzymol; 1993; 223():13-35. PubMed ID: 8271948
[No Abstract] [Full Text] [Related]
70. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
Sim RB; Sim E
Biochem J; 1981 Jan; 193(1):129-41. PubMed ID: 7305917
[TBL] [Abstract][Full Text] [Related]
71. The purification and properties of the second component of guinea-pig complement.
Kerr MA; Gagnon J
Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702
[TBL] [Abstract][Full Text] [Related]
72. Inactivation of complement by recombinant human C3 derivatives.
Spillner F; Kölln J; Bredehorst R
Adv Exp Med Biol; 2006; 586():347-60. PubMed ID: 16893083
[No Abstract] [Full Text] [Related]
73. Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.
Law SK; Minich TM; Levine RP
Biochemistry; 1984 Jul; 23(14):3267-72. PubMed ID: 6432041
[TBL] [Abstract][Full Text] [Related]
74. X-ray crystal structure of the C4d fragment of human complement component C4.
van den Elsen JM; Martin A; Wong V; Clemenza L; Rose DR; Isenman DE
J Mol Biol; 2002 Oct; 322(5):1103-15. PubMed ID: 12367531
[TBL] [Abstract][Full Text] [Related]
75. The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.
Dodds AW; Law SK; Porter RR
EMBO J; 1985 Sep; 4(9):2239-44. PubMed ID: 3852741
[TBL] [Abstract][Full Text] [Related]
76. Storage of the complement components C4, C3, and C 3-activator in the human liver as PAS-negative globular hyaline bodies.
Storch W; Riedel H; Trautmann B; Justus J; Hiemann D
Exp Pathol; 1982; 21(3):199-203. PubMed ID: 6288441
[TBL] [Abstract][Full Text] [Related]
77. Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s.
Nissen MH; Roepstorff P; Thim L; Dunbar B; Fothergill JE
Eur J Biochem; 1990 Apr; 189(2):423-9. PubMed ID: 2110898
[TBL] [Abstract][Full Text] [Related]
78. The role of the lys628 (192) residue of the complement protease, c1s, in interacting with Peptide and protein substrates.
Wijeyewickrema LC; Duncan RC; Pike RN
Front Immunol; 2014; 5():444. PubMed ID: 25278939
[TBL] [Abstract][Full Text] [Related]
79. Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s.
Garrigues RJ; Thomas S; Leong JM; Garcia BL
J Biol Chem; 2022 Nov; 298(11):102557. PubMed ID: 36183830
[TBL] [Abstract][Full Text] [Related]
80. Complete cDNA sequence of the fourth component of murine complement.
Sepich DS; Noonan DJ; Ogata RT
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5895-9. PubMed ID: 3862104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
